FDA Inspection 989444 — Neogen Corporation

Neogen Corporation — FEI 1120041

The FDA completed an inspection of Neogen Corporation on October 7, 2016 in Lansing, MI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 7, 2016
Fiscal Year
2017
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Lansing, MI (United States)

Citations

IDCFRDescription
311921 CFR 820.75(b)Lack/Inad procedure-Monitoring/Control of Validated Proces
313021 CFR 820.100(a)Lack of or inadequate procedures
41921 CFR 820.20(b)Lack of or inadequate organizational structure
419121 CFR 806.10(a)(1)Report of risk to health
54121 CFR 820.70(c)Environmental control Lack of or inadequate procedures